{
    "nctId": "NCT00910884",
    "briefTitle": "Plant Extracted Natural Compounds Impact on Stage IV Breast Cancer Survival Time and Remission.",
    "officialTitle": "Stage IV Breast Cancer Gene Expression Control Using Micro-Trace and Plant Extracted Natural G.R.A.S. (Generally Accepted As Safe), Compounds in Adjunct Therapy Alongside Conventional Cancer Protocols",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 300,
    "primaryOutcomeMeasure": "Utilize GRAS plant extracted compounds for suppression of cancer-cell replication.",
    "eligibilityCriteria": "DISEASE CHARACTERISTICS:\n\n* Diagnosis of prostate, breast, or uterine cancer\n\n  * Early or late stage disease\n* Currently waiting to initiate conventional therapy or radiotherapy OR receiving concurrent conventional chemotherapy or radiation therapy\n* Hormone receptor status not specified\n\nPATIENT CHARACTERISTICS:\n\n* Menopausal status not specified\n\nPRIOR CONCURRENT THERAPY:\n\n* See Disease Characteristics\n* Prior or concurrent chemotherapy or hormonal therapy for cancer allowed",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}